Clinical Trials Browser

Phase 2 × Overall Survival × Irinotecan × Clear all

NCT03726021 2023-03-29

Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer

Phase 2 Completed

Overall Survival